{
    "title": "Individual feed for https://www.2minutemedicine.com/feed/",
    "link": "https://www.2minutemedicine.com/feed/",
    "description": "Individual feed output.",
    "lastBuildDate": "2026-01-12T11:02:26.497506",
    "items": [
        {
            "title": "Large language models (LLMs) substantially improved patient comprehension of discharge summaries",
            "link": "https://www.2minutemedicine.com/large-language-models-llms-substantially-improved-patient-comprehension-of-discharge-summaries/",
            "description": "1. Kumar and colleagues assessed LLM’s ability to translate discharge summary notes into plain language to improve patient comprehension. 2. Patients,...",
            "pubDate": "2026-01-12T15:30:39",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2017/12/doctor-patient-6-urologic-oncology-300x150.jpg"
        },
        {
            "title": "2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]",
            "link": "https://www.2minutemedicine.com/2-minute-medicine-pharma-roundup-new-oral-gonorrhea-antibiotic-nuzolvence-zoliflodacin-late%e2%80%91december-cardiovascular-and-oncology-drug-approvals-first-targeted-complement-inhibit/",
            "description": "Oral gonorrhea antibiotic Nuzolvence approved just weeks ago The Food and Drug Administration recently approved Nuzolvence (zoliflodacin) as a first‑i...",
            "pubDate": "2026-01-12T15:00:58",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-300x200.png"
        },
        {
            "title": "2 Minute Medicine Rewind January 12th, 2026",
            "link": "https://www.2minutemedicine.com/2-minute-medicine-rewind-january-12th-2026/",
            "description": "Ethosuximide and Irritable Bowel Syndrome–Related Abdominal Pain: A Randomized Clinical Trial 1. Ethosuximide was not superior to placebo for the trea...",
            "pubDate": "2026-01-12T11:00:59",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2016/11/CC_kidneystone_hazydan_wiki_edited-300x150.png"
        },
        {
            "title": "Management of Dyspnea With High-Flow Nasal Air or Fan-A Randomized Controlled Crossover Trial",
            "link": "https://www.2minutemedicine.com/management-of-dyspnea-with-high-flow-nasal-air-or-fan-a-randomized-controlled-crossover-trial/",
            "description": "1. In patients with advanced cancer who are not hypoxemic, high-flow nasal therapy using room air and simple fan therapy provide safe, similar, and mo...",
            "pubDate": "2026-01-10T00:00:15",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2019/10/breast-cancer-cells-PD-300x150.jpg"
        },
        {
            "title": "The efficacy of preoperative evolocumab-rosuvastatin combination therapy in patients with ST-elevation myocardial infarction",
            "link": "https://www.2minutemedicine.com/the-efficacy-of-preoperative-evolocumab-rosuvastatin-combination-therapy-in-patients-with-st-elevation-myocardial-infarction/",
            "description": "1. Preoperative evolocumab combined with rosuvastatin did not significantly reduce six-month major adverse cardiovascular events but improved several ...",
            "pubDate": "2026-01-09T00:00:43",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2017/04/stemi-myocardial-infarct-300x150.jpg"
        }
    ]
}